Results

Total Results: 1,695 records

Showing results for "measured".
Users also searched for: quality measures

361. Wireless-Motility-Capsule Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/wireless-motility-capsule_executive.pdf
     May 01, 2013 - One study reported a correlation coefficient of 0.73 between gastric emptying time measured by the … WMC and 4-hour gastric emptying measured by gastric scintigraphy.10 When comparing WMC with gastric … Heightened colon motor activity measured by a wireless capsule in patients with constipation: relation … Impact of acid suppression on upper gastrointestinal function as measured by a non-invasive wireless

362. Disposition of Comments for CER 196 The Role of Immunotherapy in the Treatment of Asthma (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-196-disposition-comments-immunotherapy-asthma.pdf
     March 23, 2018 - the resource use point (page 6, line 38), as well as a short description about how compliance is measured … considered however it was assessed by the studies and have, where reported, provided how compliance was measured … Page 38 line 32 should read "measured" not "measure". Thanks for your edits. … As explained in the report and shown in the appendix, the studies measured the controller medications

363. App-F1-Surv-Report-1-Nonopioid-Pharmacol-Chronic-Pain (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-f1-surv-report-1-nonopioid-pharmacol-chronic-pain.xlsx
     May 29, 2025 - NPP_Pain Table F-1a. Pain severity for neuropathic pain Author, Year Quality Pain Population Drug Class 1 Drug Class 2 Drug 1 Drug 2 Measure Name Measure Scale Assessment Time (Wk) Time Category Grp 1 Baseline N Grp 1 Baseline Mean Pain Score Grp1 Baseline Variance Type Grp1 Baseline Variance Grp1 Baseline Lower Limi…

364. Methods Guide for Comparative Effectiveness Reviews - Expanded Guidance on Selected Quantitative Synthesis Topics (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/quantitative-synthesis-expanded-methods_methods.pdf
     March 01, 2013 - For example, Hansen et al.33 combined functional outcomes measured on different scales in placebo-controlled … combining Outcome definitions Specify whether outcome definitions or the way outcomes were measured

365. Template for Draft Reports (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/long-term-care-adults-future_research.pdf
     July 01, 2013 - Design Randomization can increase the likelihood that HCBS and NH populations are comparable on measured … Tier 2: Moderate/Low Priority How should ADLs and IADLs be measured to accurately assess service needs

366. App-F1-Surv-Report-2-Nonopioid-Pharmacol-Chronic-Pain (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-f1-surv-report-2-nonopioid-pharmacol-chronic-pain.xlsx
     May 29, 2025 - NPP_Pain Table F-1a. Pain severity for neuropathic pain Author, Year Quality Pain Population Drug Class 1 Drug Class 2 Drug 1 Drug 2 Measure Name Measure Scale Assessment Time (Wk) Time Category Grp 1 Baseline N Grp 1 Baseline Mean Pain Score Grp1 Baseline Variance Type Grp1 Baseline Variance Grp1 Baseline Lower Limi…

367. Disposition of Comments Report for The Patient-Centered Medical Home (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/patient-centered-medical-home_disposition-comments.pdf
     July 03, 2012 - We have clarified in the table and associated text that coordination of care was measured using select … Results - p. 24, line 9/10: Provide additional details on how self-reported coordination of care was measured … We clarified in the table and associated text that coordination of care was measured using items from

368. Disposition of Comments: Technical Brief No. 38_Automated Entry Patient Generated Health Data for Chronic Conditions: The Evidence on Health Outcomes (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/tech-brief-38-chronic-conditions-comments.pdf
     March 01, 2021 - How else would these be measured? … It does not appear that the report measured the health outcomes of RPM utilization based on the potential … health outcomes, and the primary purpose of this project was to document where they have been measured … Adherence measurement was specific to each clinical condition and how adherence was measured is included … For measures that it is unclear what concept was actually measured, it may be better to say health-related

369. App-F1-Surv-Report-3-Nonopioid-Pharmacol-Chronic-Pain (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-f1-surv-report-3-nonopioid-pharmacol-chronic-pain.xlsx
     May 29, 2025 - NPP_Pain Table F-1a. Pain severity for neuropathic pain Author, Year Quality Pain Population Drug Class 1 Drug Class 2 Drug 1 Drug 2 Measure Name Measure Scale Assessment Time (Wk) Time Category Grp 1 Baseline N Grp 1 Baseline Mean Pain Score Grp1 Baseline Variance Type Grp1 Baseline Variance Grp1 Baseline Lower Limi…

370. Disposition of Comments Report for Testing of CYP2C19 Variants and Platelet Reactivity for Guiding Antiplatelet Treatment (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/antiplatelet-treatment_disposition-comments.pdf
     September 25, 2013 - Most studies genotyped and analyzed one of these variants and not the other while other studies have measured … observed during the assay, or final platelet aggregation (FPA), which is related to light transmission measured … To clarify the terminology, the target quantity measured by both the index and reference test is “true … Results The majority of published reports evaluating the association between high platelet reactivity measured

371. Evidence Report on the (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/pelvic-pain_research-protocol.pdf
     February 16, 2011 - Measured with the same instrument before and after the intervention is received and in the intervention

372. Future Research Needs for Attention Deficit Hyperactivity Disorder: Effectiveness of Treatment in At-Risk Preschoolers, Long-Term Effectiveness in All Ages, and Variability in Prevalence, Diagnosis, and Treatment (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/adhd-future_research.pdf
     May 01, 2012 - KQ 2 Research among people with ADHD ages 6 years and older that compares efficacy as measured by … in children appears to have been relatively stable since the 1980s, to the extent that it has been measured … KQ 2 Research among people with ADHD ages 6 years and older that compares efficacy as measured by … Potential confounders (e.g., co-interventions, parental preferences) might not have been measured. … (KQ 2) 17 Research among people with ADHD ages 6 years and older that compares efficacy as measured

373. Pharma-Nonpharma-Ptsd-2022-Update-App-G1 (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/pharma-nonpharma-ptsd-2022-update-app-g1.xlsx
     January 01, 2022 - G-1. RoB 2 Assessment Table G-1. Risk of Bias 2 assessment of new included studies RoB Domain Bias Due to Randomization (Cochrane) or Selection Bias (AHRQ); Randomization Bias Due to Randomization (Cochrane) or Selection Bias (AHRQ); Allocation Bias Due to Randomization (Cochrane) or Selection Bias (AHRQ); Similarit…

374. Updating the Framework for AHRQ’s National Healthcare Quality and Disparities Report (NHQDR) (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/updating-framework-protocol.pdf
     September 06, 2023 - Updating the Framework for AHRQ’s National Healthcare Quality and Disparities Report (NHQDR) Evidence-based Practice Center Technical Brief Protocol Project Title: Updating the Framework for AHRQ’s National Healthcare Quality and Disparities Report (NHQDR) I. Background and Objectives for the Technical…

375. Comparative Effectiveness Review Disposition of Comments Report (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/bundled-payments-quality-effects_disposition-comments.pdf
     August 24, 2012 - the poor studies contributed information not included in other studies (e.g., unique study outcomes measured … the poor studies contributed information not included in other studies (e.g., unique study outcomes measured … the poor studies contributed information not included in other studies (e.g., unique study outcomes measured

376. Methods Guide for Comparative Effectiveness Reviews_Inclusion of Nonrandomized Studies of Interventions in Systematic Reviews of Intervention Effectiveness: An Update (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/methods-guide-inclusion-nonrandomized-studies.pdf
     September 01, 2022 - Outcome of interest is measured as the difference of predicted changes before and after intervention … In practice, not all confounders are available or can be measured. … intervention and the outcome to fully explain away a treatment 24 effect, conditional on the other measured … how important confounders were handled in the design and analysis; (3) whether the confounders were measured … These approaches rely on the assumption that the full set of confounders is known and validly measured

377. Methods Guide for Comparative Effectiveness Reviews_Inclusion of Nonrandomized Studies of Interventions in Systematic Reviews of Intervention Effectiveness: An Update (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pdf/methods-guide-inclusion-nonrandomized-studies.pdf
     September 01, 2022 - Outcome of interest is measured as the difference of predicted changes before and after intervention … In practice, not all confounders are available or can be measured. … intervention and the outcome to fully explain away a treatment 24 effect, conditional on the other measured … how important confounders were handled in the design and analysis; (3) whether the confounders were measured … These approaches rely on the assumption that the full set of confounders is known and validly measured

378. Research Protocol: Radiation Therapy for Brain Metastases (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/radiation-therapy-brain-metases-protocol.pdf
     October 10, 2019 - Quality of life as measured by validated scales 3. Cognitive function measured by any scale 4. … Functional status as measured by any scale or measure (standardized mean differences)

379. CERs Report cover (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/hip-feature-treatment-future_research.pdf
     September 23, 2010 - Higher standards or scores by funding bodies for optimally-designed and measured clinical studies was … Higher standards or scores by funding bodies for optimally-designed and measured clinical studies was

380. Omega-3-Maternity Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/omega-3-maternity_research-protocol.pdf
     May 18, 2015 - biomarkers used to estimate n-3 polyunsaturated fatty acids intakes include ALA, EPA, SDA, and DHA, and are measured … Question 2, 3 (infant exposures): • Interventions implemented within one month of birth or exposures measured … diabetes); healthy term infants), demographics; baseline n-3 intake, n-3 source, n-3 type, how n-3 intake measured